Abstract:Objective To evaluate the effect of Dioscorea pills on the immunity of mice with 4T1 breast cancer after chemotherapy and its mechanism of action. Methods Thirty-two BALB/c mice were randomly divided into a control group, a model group, a chemotherapy group and a chemotherapy plus Chinese medicine group with 8 mice in each group. Except the control group, all the other groups were injected with a 4T1 breast cancer cell suspension to build a tumor-bearing mouse model. The chemotherapy group and the chemotherapy plus Chinese medicine group were treated with Docetaxel from the 1st day after tumor formation, once in 7 days, for 21 days; Dioscorea pills were given to the chemotherapy plus Chinese medicine group by gavage from the 2nd day after Docetaxel injection, once a day, for 21 days. After treatment, the mice were sacrificed and their spleens were taken out and ground, and then flow cytometry was used to detect the levels of CD4+, CD8+, CD4+CD25+Foxp3+ Treg cells. Results Compared with the model group, the levels of CD4+, CD8+ and CD4+CD25+Foxp3+ Treg cells decreased, while CD4+/CD8+ ratio increased in the chemotherapy group and the chemotherapy plus Chinese medicine group, and the differences were significant (P < 0.05). Compared with the chemotherapy group, the levels of CD4+ cells and CD4+/CD8+ ratio increased, while the level of CD4+CD25+Foxp3+ Treg cells decreased in the chemotherapy plus Chinese medicine group, and the differences were significant (P < 0.05). Conclusions Dioscorea pills can improve the immune function of mice with breast cancer after chemotherapy.